Literature DB >> 26477959

Electrocardiographic Criteria for Left Ventricular Hypertrophy in Asians Differs from Criteria Derived from Western Populations--Community-based Data from an Asian Population.

Chang Fen Xu1, Eugene S J Tan, Liang Feng, Rajalakshmi Santhanakrishnan, Michelle M Y Chan, Shwe Zin Nyunt, Tze Pin Ng, Lieng Hsi Ling, A Mark Richards, Carolyn S P Lam, Toon Wei Lim.   

Abstract

INTRODUCTION: Electrocardiographic (ECG) criteria for left ventricular hypertrophy (LVH), such as the Cornell and Sokolow-Lyon voltage criteria were derived from Western populations. However, their utility and accuracy for diagnosing echocardiographic LVH in Asian populations is unclear. The objective of this study was to assess the accuracy of ECG criteria for LVH in Asians and to determine if alternative gender-specific ECG cut-offs may improve its diagnostic accuracy.
MATERIALS AND METHODS: ECG and echocardiographic assessments were performed on 668 community-dwelling Asian adults (50.9% women; 57 ± 10 years) in Singapore. The accuracy of ECG voltage criteria was compared to echocardiographic LVH criteria based on the American Society of Echocardiography guidelines, and Asian ethnicity and gender-specific partition values.
RESULTS: Echocardiographic LVH was present in 93 (13.6%) adults. Cornell criteria had low sensitivity (5.5%) and high specificity (98.9%) for diagnosing LVH. Modified gender specific cut-offs (18 mm in women, 22 mm in men) improved sensitivity (8.8% to 17.5%, 0% to 14.7%, respectively) whilst preserving specificity (98.2% to 94.2%, 100% to 95.8%). Similarly, Sokolow-Lyon criteria had poor sensitivity (7.7%) and high specificity (96.1%) for diagnosing LVH. Lowering the cut-off value from 35 mm to 31 mm improved the sensitivity in women from 3.5% to 14% while preserving specificity at 94.2%. A cut-off of 36 mm was optimal in men (sensitivity of 14.7%, specificity of 95.5%).
CONCLUSION: Current ECG criteria for LVH derived in Western cohorts have limited sensitivity in Asian populations. Our data suggests that ethnicity- and gender-specific ECG criteria may be needed.

Entities:  

Mesh:

Year:  2015        PMID: 26477959

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  5 in total

1.  Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; Ramachandran S Vasan; Thomas J Wang; Jonathan Yap; Liang Feng; Keng B Yap; Hean Y Ong; Tze P Ng; Arthur Mark Richards; Carolyn S P Lam; Jennifer E Ho
Journal:  J Am Heart Assoc       Date:  2016-03-25       Impact factor: 5.501

2.  Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.

Authors:  Sanne M Snelder; Sweder W E van de Poll; Lotte E de Groot-de Laat; Isabella Kardys; Felix Zijlstra; Bas M van Dalen
Journal:  Clin Cardiol       Date:  2020-01-28       Impact factor: 2.882

3.  Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes.

Authors:  Xueli Jiang; Xin Quan; Jun Yang; Xianliang Zhou; Aihua Hu; Yuqing Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-01       Impact factor: 3.738

4.  Correlations of circulating miR-26b level with left ventricular hypertrophy and cardiac function in elderly patients with hypertension.

Authors:  Jian Fu; Fang Lin; Zhengxia Pan; Chun Wu
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

5.  The association between ECG criteria and Echo criteria for left ventricular hypertrophy in a general Chinese population.

Authors:  Tingting Lv; Yifang Yuan; Jing Yang; Guijin Wang; Lingyun Kong; Huijuan Li; Xingjie Li; Yingxian Sun; Xuewen Li; Zheng Zhang; Xiaoshu Cheng; Lirong Wu; Xuerui Tan; Bing Han; Hua Li; Zhaoguo Zhang; Jiayu Wang; Yangfeng Wu; Yanfang Wang; Jihong Guo; Ping Zhang
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-07-26       Impact factor: 1.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.